![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 23, 2020 7:31:02 PM
See- current Q p.31:
Revenue
We generated revenue of $0 and $0.4 million for the three months ended September 30, 2020 and 2019, respectively. Revenue during the three months ended September 30, 2019 represented the initial non-refundable payment from the exclusive license agreement signed with Alfasigma S.p.A., a global pharmaceutical company (see Note 7. Exclusive License Agreement to the condensed consolidated financial statements).
It's a little insane to me though, that a company that's been in existence since 2005 has only managed a handful of statistically insignificant trails and some pre-clinical tests... and a single 'deal'
15yrs of what... ?
Lots of 'Leo apologists' here and not much accountability.
Businesses exist to make money within this sector.
To-date IPIX has only cost shareholders money, if they're of the long-term variety.
Not funding the company properly out of the gate was mistake #1.
Not running trials with endpoints to target not just the indications but also specific 'interested' prospective partners is an ongoing issue.
Years of PR's concerning 'partnership negotiations' etc, and nothing ever coming to fruition is concerning.
...and yeah this certainly isn't 'the investment for me', but it's not due to the product, as much as it's due to a grossly incompetent management suite. Rather... entity.
There's no such thing as 'bad teams', only bad leaders.
We'll see what happens with COVID... fingers are crossed.
But you certainly are exactly nobody to decide what 'investments are for me' or aren't for me. I've done my DD related to this, and currently in WAY too deep to walk.
If you think Leo has done an amazing job in driving shareholder value since 2005, then I'd question your personal level of investment here, and your understanding of what qualifies as an 'economically sound investment'.
...and there are other funding mechanisms available to them. It's up to mgmnt to utilize them to greatest-effect to progress the products in a timely and effective manner. Grants, partnerships etc. How's that going so far?
Current Q, p.28 (again):
An earlier grant application was unsuccessful. At the time of that grant filing deadline, the only research data available was limited to non-human Vero cells. Subsequent to the filing, human cell line experiments were completed and the data is now available. Additional grant applications incorporating the new data are planned for submission before the end of 2020.
Are you aware that ipix doesn’t have any revenues and that they either have to borrow money or dilute their stock. These trials aren’t free. If this makes you uncomfortable then maybe this isn’t the investment for you.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM